Forshing Lui¹*, Ning Zhong², Kaho Wong³, Stella Knowlton¹, Jessa Alcaide¹ and Michael Ysit¹

¹California Northstate University College of Medicine, Elk Grove, CA, USA
²Kaiser Permanente Medical Center, Sacramento, CA, USA
³Kaiser Permanente Medical Center, Roseville, CA, USA

*Corresponding Author: Forshing Lui, California Northstate University College of Medicine, Elk Grove, CA, USA.

Received: October 21, 2021; Published: November 12, 2021

Abstract

There are no lymphatics within the brain like other organs in our body with traditional anatomical understanding until Iliff and Nedergaard demonstrated a system of cerebrospinal and brain interstitial fluid flow systems that appears to be similar to the lymphatic system in rodents. They created the term “glymphatics”. More recent studies by using MRI tracer studies in humans demonstrated evidences of a similar glymphatic system in humans. It is logical to believe that such a system functions as an important waste clearance system in health and disease. However, the function of such a system has been questioned by more recent studies. There has never been any real human case to confirm the pathophysiologically the dysfunction of such a system as the reason for the underlying disease. Furthermore, there has never been any explanation how beta-amyloid synthesized in the brain can be transported retrogradely to the small brain arteries and arterioles in amyloid angiopathy.

We report a case of relatively rapid development of amyloid angiopathy over a few years after an acute subarachnoid hemorrhage secondary to rupture of the posterior communicating aneurysm. The amyloid angiopathy is relatively localized over the site of subarachnoid hemorrhage. There are also associated local changes and amyloid deposition in the brain parenchyma.

We believe this case evidently and adequately demonstrated the function and dysfunction of the glymphatic system in waste clearance and movement of solutes in the brain parenchyma. It also demonstrated how a-beta amyloid is synthesized in the brain parenchyma and transported retrogradely towards and got deposited in the small cerebral arteries in amyloid angiopathy.

Keywords: Glymphatics; A-beta Amyloid; Amyloid Angiopathy; Proteinopathy

References

1. Iliff JJ Wang M., et al. “A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β”. Science Translational Medicine147 (2012): 147ra111.
2. Iliff J and Simon M. “The glymphatic system supports convective exchange of cerebrospinal fluid and brain interstitial fluid that is mediated by perivascular aquaporin-4”. The Journal of Physiology17 (2019): 4417.
3. Mestre H., et al. “Aquaporin-4-dependent glymphatic solute transport in the rodent brain”. Elife 7 (2018): e40070.
4. Davoodi-Bojd E., et al. “Modeling glymphatic system of the brain using MRI”. Neuroimage 188 (2019): 616-627.
5. Jessen NA., et al. “The glymphatic system: a beginner’s guide”. Neurochemical Research 12 (2015): 2583-2599.
6. Smith AJ., et al. “Test of the 'glymphatic' hypothesis demonstrates diffusive and aquaporin-4-independent solute transport in rodent brain parenchyma”. Elife 6 (2017): e27679.
7. Smith AJ and Verkman AS. “The “glymphatic” mechanism for solute clearance in Alzheimer's disease: game changer or unproven speculation?” The FASEB Journal2 (2018): 543-551.
8. Ringstad G., et al. “Brain-wide glymphatic enhancement and clearance in humans assessed with MRI”. JCI Insight13 (2018).
9. Taoka T and Naganawa S. “Imaging for central nervous system (CNS) interstitial fluidopathy: disorders with impaired interstitial fluid dynamics”. Japanese Journal of Radiology1 (2021): 1-4.
10. Watts R., et al. “Measuring glymphatic flow in man using quantitative contrast-enhanced MRI”. American Journal of Neuroradiology4 (2019): 648-651.
11. Eide PK., et al. “Magnetic resonance imaging provides evidence of glymphatic drainage from human brain to cervical lymph nodes”. Scientific Reports1 (2018): 1-10.
12. Hardy JA and Higgins GA. “Alzheimer's disease: the amyloid cascade hypothesis”. Science 5054 (1992): 184-186.
13. Tanzi RE. “The synaptic Aβ hypothesis of Alzheimer disease”. Nature Neuroscience 8 (2005): 977-979.
14. Chen GF., et al. “Amyloid beta: structure, biology and structure-based therapeutic development”. Acta Pharmacologica Sinica 9 (2017): 1205-1235.
15. Engler H., et al. “Two-year follow-up of amyloid deposition in patients with Alzheimer's disease”. Brain 11 (2006): 2856-2866.
16. Yamada M. “Cerebral amyloid angiopathy: emerging concepts”. Journal of Stroke1 (2015): 17.
17. Chen GF., et al. “Amyloid beta: structure, biology and structure-based therapeutic development”. Acta Pharmacologica Sinica9 (217): 1205-1235.
18. Plog BA and Nedergaard M. “The glymphatic system in central nervous system health and disease: past, present, and future”. Annual Review of Pathology: Mechanisms of Disease 13 (2018): 379-394.
19. Taoka T and Naganawa S. “Neurofluid dynamics and the glymphatic system: a neuroimaging perspective”. Korean Journal of Radiology11 (2020): 1199.
20. Orešković D and Klarica M. “The formation of cerebrospinal fluid: nearly a hundred years of interpretations and misinterpretations”. Brain Research Reviews2 (2010): 241-262.
21. Nakada T and Kwee IL. “Fluid dynamics inside the brain barrier: current concept of interstitial flow, glymphatic flow, and cerebrospinal fluid circulation in the brain”. The Neuroscientist2 (2019): 155-166.
22. Watts R., et al. “Measuring glymphatic flow in man using quantitative contrast-enhanced MRI”. American Journal of Neuroradiology4 (2019): 648-651.
23. Eide PK., et al. “Magnetic resonance imaging provides evidence of glymphatic drainage from human brain to cervical lymph nodes”. Scientific Reports1 (2018): 1-10.
24. Iliff JJ and Nedergaard M. “Is there a cerebral lymphatic system?” Stroke6-1 (2013): S93-S95.
25. Kaur J., et al. “Magnetic resonance imaging and modeling of the glymphatic system”. Diagnostics6 (2010): 344.
26. Yang L., et al. “Evaluating glymphatic pathway function utilizing clinically relevant intrathecal infusion of CSF tracer”. Journal of Translational Medicine 1 (2013): 1-9.
27. Kress BT., et al. “Impairment of paravascular clearance pathways in the aging brain”. Annals of Neurology 6 (2014): 845-861.
28. Reeves BC., et al. “Glymphatic system impairment in Alzheimer’s disease and idiopathic normal pressure hydrocephalus”. Trends in Molecular Medicine3 (2020): 285-295.
29. Xie L., et al. “Sleep drives metabolite clearance from the adult brain”. Science6156 (2013): 373-377.
30. Hauglund NL., et al. “Cleaning the sleeping brain–the potential restorative function of the glymphatic system”. Current Opinion in Physiology 15 (2020): 1-6.
31. Biffi A and Greenberg SM. “Cerebral amyloid angiopathy: a systematic review”. Journal of Clinical Neurology1 (2011): 1-9.
32. Greenberg SM and Charidimou A. “Diagnosis of cerebral amyloid angiopathy: evolution of the Boston criteria”. Stroke2 (2018): 491-497.
33. Brenowitz WD., et al. “Cerebral amyloid angiopathy and its co-occurrence with Alzheimer's disease and other cerebrovascular neuropathologic changes”. Neurobiology of Aging10 (2015): 2702-2708.
34. Rowe CC., et al. “Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging”. Neurobiology of Aging8 (2010): 1275-1283.

Citation

Citation: Forshing Lui., et al. “A Case of Localized Amyloid Angiopathy Following Aneurysmal Subarachnoid Hemorrhage - Strong Evidence of Dysfunction of the Glymphatic System”. Acta Scientific Neurology 4.12 (2021): 12-18.

Copyright

Copyright: © 2021 Forshing Lui., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.